Sort
64,565 grants matching “drug discovery”
Core 1
$1,426,826Mark A Musen · Stanford University · U54 · FY2014 · HG
Development of novel NLRP3 inflammasome inhibitors for intervening in Alzheimer's disease
$1,426,573Shijun Zhang · Virginia Commonwealth University · U01 · FY2022 · AG
Identifying resilience proteins in key motor tissues that drive motor and cognitive decline and offset the negative effects of ADRD pathologies within and outside the brain
$1,426,500Aron S Buchman · Rush University Medical Center · R01 · FY2024 · AG
Next generation drugs for bipolar depression and maintenance
$1,425,888Thomas H Large · Blue Oak Pharmaceuticals, Inc. · R44 · FY2021 · MH
RP1: Targeting Beclin 1 complexes for broad-spectrum anti-infective therapeutics
$1,425,661Beth C Levine · Ut Southwestern Medical Center · U19 · FY2020 · AI
Rare Bronchiectatic Diseases Consortium
$1,425,304Kenneth N. Olivier · Univ Of North Carolina Chapel Hill · U54 · FY2025 · HL
Modular nanophotonic probes for dense neural recording at single-cell resolution
$1,424,715Michael L Roukes · California Institute Of Technology · U01 · FY2014 · NS
HLS- A Phase 1 Open-Label Dose-Escalation with Expansion Study of SX-682 in MDS Patients
$1,424,426Stuart J Kahn · Syntrix Biosystems, Inc. · R44 · FY2019 · HL
Small-molecule inhibitors of flavivirus entry
$1,424,274Priscilla Li-Ning Yang · Harvard Medical School · U19 · FY2018 · AI
Molecular Genetics of Inherited Neurological Diseases
$1,423,947Xandra Owens Breakefield · Massachusetts General Hospital · P01 · FY2008 · NS
Human Melanoma: Etiology, Progression and Therapy
$1,422,871Meenhard Herlyn · Wistar Institute · P01 · FY2015 · CA
NHLBI MAINTENANCE OF CANINE MODELS OF HUMAN BLEEDING DISORDERS
$1,422,577Timothy Nichols · Univ Of North Carolina Chapel Hill · N01 · FY2022 · HL
NHLBI MAINTENANCE OF CANINE MODELS OF HUMAN BLEEDING DISORDERS
$1,422,512Timothy Nichols · Univ Of North Carolina Chapel Hill · N01 · FY2021 · HL
NHLBI MAINTENANCE OF CANINE MODELS OF HUMAN BLEEDING DISORDERS
$1,422,480Timothy Nichols · Univ Of North Carolina Chapel Hill · N01 · FY2023 · HL
Molecular approaches to understand vector-host and vector-pathogen interactions
$1,421,968Jesus Valenzuela · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Response Therapies for MDR-TB
$1,421,958Ian M Orme · Colorado State University · U01 · FY2009 · AI
Human Melanoma: Etiology, Progression and Therapy
$1,421,890Meenhard Herlyn · Wistar Institute · P01 · FY2012 · CA
Regulation of Ras-Dependent Signal Transduction Pathways
$1,421,723Deborah Morrison · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Optimization of efflux avoidance and inhibition for antibiotic development
$1,421,601Helen I. Zgurskaya · University Of Oklahoma · R01 · FY2018 · AI
UMDNJ/Rutgers University CounterACT Research Center of Excellence
$1,421,485Jeffrey D Laskin · Rbhs-Robert Wood Johnson Medical School · U54 · FY2016 · AR
DCTD Computer Support
$1,421,384David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2013 · CA
Whole blood filter paper assay for Alzheimers Disease
$1,421,226Bruce E. Seligmann · Biospyder Technologies, Inc. · R44 · FY2023 · AG
Open Drug Discovery Center for Alzheimer's Disease
$1,420,230Allan I Levey · Emory University · U54 · FY2019 · AG
Dietary Biomarkers Development Center at Harvard University
$1,420,147Frank B Hu · Harvard University D/B/A Harvard School Of Public Health · U2C · FY2024 · DK
Center for Undiagnosed Diseases at Stanford
$1,420,000Euan A Ashley · Stanford University · U01 · FY2018 · HG